Skip to main navigation Skip to search Skip to main content

Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity

  • Nicolas Léveillé
  • , Ran Elkon
  • , Veronica Davalos
  • , Vijayalaxmi Manoharan
  • , Dave Hollingworth
  • , Joachim Oude Vrielink
  • , Carlos le Sage
  • , Carlos A. Melo
  • , Hugo M. Horlings
  • , Jelle Wesseling
  • , Jernej Ule
  • , Manel Esteller
  • , Andres Ramos
  • , Reuven Agami

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

MicroRNAs (miRNAs) interact with 3'-untranslated regions of messenger RNAs to restrict expression of most protein-coding genes during normal development and cancer. RNA-binding proteins (RBPs) can control the biogenesis, stability and activity of miRNAs. Here we identify RBM38 in a genetic screen for RBPs whose expression controls miRNA access to target mRNAs. RBM38 is induced by p53 and its ability to modulate miRNA-mediated repression is required for proper p53 function. In contrast, RBM38 shows lower propensity to block the action of the p53-controlled miR-34a on SIRT1. Target selectivity is determined by the interaction of RBM38 with uridine-rich regions near miRNA target sequences. Furthermore, in large cohorts of human breast cancer, reduced RBM38 expression by promoter hypermethylation correlates with wild-type p53 status. Thus, our results indicate a novel layer of p53 gene regulation, which is required for its tumour suppressive function
Original languageEnglish
Pages (from-to)513
JournalNature communications
Volume2
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity'. Together they form a unique fingerprint.

Cite this